Arcus Biosciences (RCUS)
(Delayed Data from NYSE)
$18.09 USD
-0.28 (-1.52%)
Updated Oct 14, 2024 04:00 PM ET
After-Market: $18.09 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Earnings News For RCUS
-
Arcus Biosciences, Inc. (RCUS) Reports Q2 Loss, Tops Revenue Estimates
-
Arcus Biosciences Reports Second-Quarter 2024 Financial Results and Provides a Pipeline Update
-
Arcus Biosciences, Inc. (RCUS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
-
Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Tops Revenue Estimates
-
Arcus Biosciences Reports First-Quarter 2024 Financial Results and Provides a Pipeline Update
-
Will Arcus Biosciences, Inc. (RCUS) Report Negative Earnings Next Week? What You Should Know
-
Arcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline Update
-
Arcus Biosciences Reports Third Quarter 2023 Financial Results and Provides a Pipeline Update
-
Arcus Biosciences, Inc. (RCUS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
-
Arcus Biosciences, Inc. (RCUS) Reports Q2 Loss, Misses Revenue Estimates
-
Arcus Biosciences Reports Second-Quarter 2023 Financial Results and Provides a Pipeline Update
-
Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Tops Revenue Estimates
-
Arcus Biosciences Reports First Quarter 2023 Financial Results and Provides a Pipeline Update
-
Earnings Preview: Arcus Biosciences, Inc. (RCUS) Q1 Earnings Expected to Decline
-
Arcus Biosciences, Inc. (RCUS) Reports Q4 Loss, Tops Revenue Estimates
-
Arcus Biosciences Reports Fourth-Quarter and Full-Year 2022 Financial Results and Provides a Pipeline Update
-
Arcus Biosciences, Inc. (RCUS) Reports Q3 Loss, Tops Revenue Estimates
-
Arcus Biosciences Reports Third Quarter 2022 Financial Results and Provides a Pipeline Update
-
Arcus Biosciences, Inc. (RCUS) Reports Q2 Loss, Tops Revenue Estimates
-
Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Lags Revenue Estimates
-
Arcus Biosciences, Inc. (RCUS) Q4 Earnings and Revenues Surpass Estimates
-
Arcus Biosciences, Inc. (RCUS) Reports Q3 Loss, Tops Revenue Estimates
-
Earnings Preview: Arcus Biosciences, Inc. (RCUS) Q3 Earnings Expected to Decline
-
Arcus Biosciences, Inc. (RCUS) Reports Q2 Loss, Lags Revenue Estimates
-
Will Arcus Biosciences, Inc. (RCUS) Report Negative Q2 Earnings? What You Should Know